Literature DB >> 2470538

Concentrations of tumor-associated trypsin inhibitor and C-reactive protein in serum in acute pelvic inflammatory disease.

J Paavonen1, M Lehtinen, M Lehto, S Laine, R Aine, L Räsänen, U H Stenman.   

Abstract

We measured tumor-associated trypsin inhibitor (TATI) and C-reactive protein (CRP) in serum of 29 patients with proven pelvic inflammatory disease (PID). TATI values were increased in seven (24%), paralleling increases in CRP. TATI was increased by about 3.5-fold in seven of eight patients with CRP concentrations greater than 90 mg/L, but in none of 21 patients with CRP concentrations less than 90 mg/L. TATI concentration and severity of PID as determined by laparoscopy or endometrial biopsy were not correlated. These results suggest that, in severe infections, regulation of TATI synthesis resembles that of acute-phase proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470538

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.

Authors:  M Medl; E Ogris; C Peters-Engl; S Leodolter
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

Review 2.  Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers.

Authors:  Milena Matuszczak; Maciej Salagierski
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.